There will be limited supply of Gardasil9 (HPV) vaccine until late November 2017. The shortage is due to demand significantly exceeding the forecast uptake for the vaccine during 2017, coupled with a delay to the scheduled arrival of new stock into New Zealand. Until the release of new stock in late November, distribution of the remaining stock will be limited to school based programme vaccinators.

Message from Propharma.